Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Sequencing breast cancer scale-up in LMICs: Using service assessment to shape national priorities in Ethiopia

Dr Yared Tilahun - Clinton Health Access Initiative (CHAI), Boston, USA
Sequencing breast cancer scale-up in LMICs: Using service assessment to shape national priorities in Ethiopia ( Dr Yared Tilahun - Clinton Health Access Initiative (CHAI), Boston, USA )
13 Oct 2026

Political prioritisation as a driver of vaccine introduction: Evidence from Nigeria’s HPV rollout

Amina Abdulkarim - Solina Centre for International Development and Research (SCIDaR), Abuja, Nigeria
Political prioritisation as a driver of vaccine introduction: Evidence from Nigeria’s HPV rollout ( Amina Abdulkarim - Solina Centre for International Development and Research (SCIDaR), Abuja, Nigeria )
13 Oct 2026

Cost of standard-of-care cancer treatment and financing gaps under AB PM-JAY in India

Dr Abhishek Shankar - All India Institute Of Medical Sciences, Delhi, India
Cost of standard-of-care cancer treatment and financing gaps under AB PM-JAY in India ( Dr Abhishek Shankar - All India Institute Of Medical Sciences, Delhi, India )
12 Oct 2026

Choice of wording may influence global acceptance of adapted childhood cancer treatment guidelines

Dr Caitlyn Duffy - St. Jude Children’s Research Hospital, Memphis, USA
Choice of wording may influence global acceptance of adapted childhood cancer treatment guidelines ( Dr Caitlyn Duffy - St. Jude Children’s Research Hospital, Memphis, USA )
12 Oct 2026

Multilevel factors shaping blinatumomab delivery across diverse LMICs

Dr Caitlyn Duffy - St. Jude Children’s Research Hospital, Memphis, USA
Multilevel factors shaping blinatumomab delivery across diverse LMICs ( Dr Caitlyn Duffy - St. Jude Children’s Research Hospital, Memphis, USA )
12 Oct 2026

Zidesamtinib shows promising efficacy in TKI-naïve ROS1-positive advanced NSCLC

Dr Alexander Drilon - Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center, New York, USA
Zidesamtinib shows promising efficacy in TKI-naïve ROS1-positive advanced NSCLC ( Dr Alexander Drilon - Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center, New York, USA )
8 Oct 2026

Subcutaneous tarlatamab shows encouraging efficacy in previously treated extensive-stage SCLC

Dr Luis Paz-Ares - 12 de Octubre University Hospital, Madrid, Spain
Subcutaneous tarlatamab shows encouraging efficacy in previously treated extensive-stage SCLC ( Dr Luis Paz-Ares - 12 de Octubre University Hospital, Madrid, Spain )
6 Oct 2026

Pembrolizumab plus chemotherapy shows pathological responses in resectable pleural mesothelioma

Dr Giulia Pasello - University of Padua, Padua, Italy
Pembrolizumab plus chemotherapy shows pathological responses in resectable pleural mesothelioma ( Dr Giulia Pasello - University of Padua, Padua, Italy )
6 Oct 2026

Subcutaneous tarlatamab shows promising safety and activity in previously treated extensive-stage SCLC

Dr Pedro Rocha - Vall d'Hebron University Hospital, Barcelona, Spain
Subcutaneous tarlatamab shows promising safety and activity in previously treated extensive-stage SCLC ( Dr Pedro Rocha - Vall d'Hebron University Hospital, Barcelona, Spain )
1 Oct 2026

Drone delivery could improve access to childhood cancer medicines in Ghana

Dr Dhwani Babla - St. Jude Children’s Research Hospital, Memphis, USA
Drone delivery could improve access to childhood cancer medicines in Ghana ( Dr Dhwani Babla - St. Jude Children’s Research Hospital, Memphis, USA )
29 Sep 2026

Adjuvant osimertinib delivers sustained long term survival benefit in EGFR mutated NSCLC

Dr Roy Herbst - Dartmouth Cancer Center, Lebanon, USA
Adjuvant osimertinib delivers sustained long term survival benefit in EGFR mutated NSCLC ( Dr Roy Herbst - Dartmouth Cancer Center, Lebanon, USA )
28 Sep 2026

Cemiplimab shows strong survival benefit in KRAS G12C positive advanced NSCLC

Prof David Gandara - University of California Davis Comprehensive Cancer Center, Sacramento, USA
Cemiplimab shows strong survival benefit in KRAS G12C positive advanced NSCLC ( Prof David Gandara - University of California Davis Comprehensive Cancer Center, Sacramento, USA )
28 Sep 2026